267P Pathological complete response after neoadjuvant chemotherapy plus pertuzumab and trastuzumab for HER2+ early breast cancer: Real-world data from NeoPowER study
| Autor: | Canino, F., Barbolini, M., De Giorgi, U.F.F., Gianni, L., Maestri, A., Moscetti, L., Omarini, C., Zamagni, C., Costantini, R. Cuoghi, Tamburrano, F., Antonelli, G., Baglio, F., Belluzzi, L., Martinelli, G., Natalizio, S., Ponzoni, O., Dominici, M., Piacentini, F. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S289-S290 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|